Globavir Company
A New Approach to Treating Global Infectious Diseases
%20.jpg)
.png)
(INV)%20.jpg)
Founded Date:
2013-07-01
Last Funding Type:
Series B
Headquarters:
Los Altos, California, United States
Investors Number:
2.0
Technology:
Biotechnology, Health Care, Health Diagnostics, Therapeutics
Employee Number:
11-50
Industry:
Drug Repurposing
Estimated Revenue:
Less than $1M
Last Funding Date:
2018-05-01
Funding Status:
Early Stage Venture
Total Funding:
11500000.0